What's in Caja Costarricense de Seguro Social's pipeline?

Caja Costarricense de Seguro Social has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Caja Costarricense de Seguro Social's portfolio?

Top competitors by shared drug class: Alimentiv Inc., Chong Kun Dang Pharmaceutical, Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Janssen Pharmaceutical K.K., Second Affiliated Hospital, School of Medicine, Zhejiang University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/caja-costarricense-de-seguro-social.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Caja Costarricense de Seguro Social — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Caja Costarricense de Seguro Social pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Risankizumab (RISA)	Risankizumab (RISA)	marketed	IL-23 inhibitor monoclonal antibody	IL-23 p19 subunit	Immunology

Therapeutic area mix

Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Alimentiv Inc. · 1 shared drug class
Chong Kun Dang Pharmaceutical · 1 shared drug class
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · 1 shared drug class
Janssen Pharmaceutical K.K. · 1 shared drug class
Second Affiliated Hospital, School of Medicine, Zhejiang University · 1 shared drug class
Sun Pharmaceutical Industries Limited · 1 shared drug class
University of Calgary · 1 shared drug class
University of North Carolina, Chapel Hill · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Caja Costarricense de Seguro Social:

Cite this brief

Drug Landscape (2026). Caja Costarricense de Seguro Social — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/caja-costarricense-de-seguro-social. Accessed 2026-05-17.